Cargando…
The LIN28B–let‐7–PBK pathway is essential for group 3 medulloblastoma tumor growth and survival
Children with Group 3 medulloblastoma (G3 MB) have a very poor prognosis, and many do not survive beyond 5 years after diagnosis. A factor that may contribute to this is the lack of available targeted therapy. Expression of protein lin‐28 homolog B (LIN28B), a regulator of developmental timing, is u...
Autores principales: | Shahab, Shubin W., Roggeveen, Christianna M., Sun, Jiarong, Kunhiraman, Haritha, McSwain, Leon F., Juraschka, Kyle, Kumar, Sachin A., Saulnier, Olivier, Taylor, Michael D., Schniederjan, Matthew, Schnepp, Robert W., MacDonald, Tobey J, Kenney, Anna Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483609/ https://www.ncbi.nlm.nih.gov/pubmed/37341142 http://dx.doi.org/10.1002/1878-0261.13477 |
Ejemplares similares
-
IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma
por: Kunhiraman, Haritha, et al.
Publicado: (2023) -
MDB-03. DFMO AS A TREATMENT STRATEGY IN GROUP 3 MEDULLOBLASTOMA
por: Shahab, Shubin, et al.
Publicado: (2023) -
EMBR-12. TARGETING THE RNA-BINDING PROTEIN LIN28B IN GROUP 3 MEDULLOBLASTOMA
por: Shahab, Shubin, et al.
Publicado: (2021) -
MEDB-63. Deciphering the role of LIN28B in Group 3 medulloblastoma
por: Shahab, Shubin, et al.
Publicado: (2022) -
Medulloblastoma and the DNA Damage Response
por: McSwain, Leon F., et al.
Publicado: (2022)